Weekly Report: what happened at LifeTech Scientific last week (0224-0228)?
Weekly Report · 03/02 22:02
Asian Growth Stocks With Strong Insider Confidence
Simply Wall St · 02/27 04:05
Weekly Report: what happened at LifeTech Scientific last week (0217-0221)?
Weekly Report · 02/23 22:02
LifeTech Scientific And 2 More Penny Stocks With Promising Potential
Simply Wall St · 02/17 03:11
Weekly Report: what happened at LifeTech Scientific last week (0210-0214)?
Weekly Report · 02/16 22:02
Weekly Report: what happened at LifeTech Scientific last week (0203-0207)?
Weekly Report · 02/09 22:02
About LifeTech Scientific
LifeTech Scientific Corp is a company principally engaged in the development, manufacturing and marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The Company operates through three segments. The Structural Heart Diseases Business segment is engaged in the trading and manufacturing of congenital heart diseases occluders and left atrial appendage (LAA) occluders. The Peripheral Vascular Diseases Business segment is engaged in the trading and manufacturing of vena cava filters and stent grafts. The Cardiac Pacing and Electrophysiology Business segment is engaged in the trading and manufacturing of pacemakers. The Company mainly conducts its businesses in the domestic and foreign markets.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. ① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0
commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more
information, please visit: https://www.webull.hk/pricing Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.